91/100 A+ · Elevated risk
1 risk flag to review TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.
  • 🟠 3 outstanding charges / secured lending

MED-I-PANT (U.K.) LIMITED

Active Private Limited Company 📍 leighton buzzard 46180 Active for 34 years

Private Limited Company · RC 02695429 · Active since 1992

A+

Overview

MED-I-PANT (U.K.) LIMITED is a Private Limited Company registered in LEIGHTON BUZZARD, United Kingdom, since 1992. The company operates in the 46180 sector. With reported revenue of 20.8M GBP in 2025. Its TraceComp score of 91 (A+) indicates solid fundamentals and low apparent risk. With 34 years of operations, the company has an established track record in its market.

Company Information

Registration Number
02695429
Legal Form
Private Limited Company
Registered
1992-03-10
Address
leighton buzzard, LU7 4AJ

Financial Profile

Latest filed accounts: FY 2025

Revenue (2025) 20,803,475 GBP
Net Income 2,164,491 GBP
Total Assets 11,367,830 GBP
Altman Z 4.31 safe

Multi-year financials & ratios

2 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Charges & Secured Lending

3 outstanding of 8 registered charges.

Who the charges are secured to (lenders), classification and dates.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Public Contracts Won

Awarded 3 public-sector contracts totalling GBP 236,150,000 (UK public procurement).

Which public buyers, contract titles, values and award dates.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Risk Signals

No adverse legal events have been recorded for this company.

  • Profitable: positive net income in FY 2025
  • Current ratio 2.97 — comfortable short-term liquidity
  • Altman Z-Score in the safe zone

Data Sources & Freshness

Data sourced from: bulk register.